GIFT-REPORT-Glutamat-MSG.pdf

GIFT-Report
MSG – Glutamat – Geschmacksverstärker
Wo findet man Glutamat und MSG - Geschmacksverstärker
In der Industriefachsprache wird auch von einem fünften Geschmack gesprochen, der nichts anderes
ist als das Ergebnis des Geschmacksverstärkers MSG.
Der Name des fünften Geschmacks stammt aus dem Japanischen:
„umami“ bedeutet ungefähr „fleischig“ oder „herzhaft“. Speisen, die „umami“ schmecken,
fallen jedem sofort ein: Parmesankäse, Lasagne, Bouillon, Tomatensaft, Sardinen, Makrelen
und Thunfisch.
Mononatriumglutamat (MSG), Dinatriuminosinat (DSI) und Dinatriumguanylat (DSG), wobei
MSG die wichtigste Rolle spielt. Im europäischen System der Nahrungsmittel-Zusatzstoffe
(„E-Nummern“) ist MSG als E 621 aufgeführt. DSI, dem vorläufig die Nummer E 631 zugeteilt
wurde, ist die zweitwichtigste Umami-Substanz und ist besonders reichlich in Sardinen,
Bonito, Makrelen, Thunfisch und Schweinefleisch enthalten. DSG, die dritte Umami-
Komponente, wurde als solche erst 1960 von Dr. Akira Kuninaka erkannt und kommt vor
allem in Pilzen wie Shiitake, Matsutake, Enokitake und Trüffeln vor.
Man kaufe nichts mit Glutamat, Geschmacksverstärker oder E-Nummern der 600er-Serie
(auch "E605" ist ein Nervengift), Kaliumglutamat, Calciumglutamat, oder Glutaminsäure.
Guanylat wirkt noch eine Zehnerpotenz stärker als Glutamat - Finger weg!
Man kaufe nichts, was mit "Würz-" beginnt oder so etwas enthält. (Würze, Würzsalz, Würzsoße,
Würzstoff, Würzmittel etc. Auch Sojasoße ist "Würze". "Würze" ist eine beliebige Substanz zum
geschmacklichen Aufpeppen – und normalerweise glutamathaltig. Da "Würze" als Synonym für
Geschmacksverstärker gilt, muss dieser auf Würzsoßen nicht extra ausgewiesen sein.
Man kaufe keine Fertignahrung uneindeutiger Zusammensetzung. Die Inhaltsstoffe von Zutaten
müssen nämlich nicht genannt sein. ("Mit Pizzasoße","mit Salamischeiben","mit Ketchup" usw. – hier
kann alles Mögliche drin sein).
Weil die Vokabel Glutamat in der Bio-Sphäre einen schlechten Klang hat, taucht sie dort nicht auf
dem Etikett auf. Das Glutamat ist dort getarnt, in den Bio-Suppenwürfeln des Ökoriesen etwa als
"Hefeextrakt". In der "Klaren Suppe", wie die Firma auf Nachfrage mitteilte, seien 2,7 Prozent
Glutamat enthalten, im Brühwürfel ("salzarm") 4,9 Prozent. Lustigerweise enthält die Gemüsebrühe
der Firma Rapunzel gar den Hinweis: "Ganz ohne zugesetzte Geschmacksverstärker" - trotz Glutamat
unterm Tarnkäpplein des Hefeextrakts.
www.giftig.me Seite 1

VERSTECKTES FREIES GLUTAMAT:
DIE GÄNGIGSTEN “CODENAMEN”
Hinter den folgenden E-Nummern verbergen sich Glutamate:
E620 – Glutaminsäure
E621 – Mononatriumglutamat (engl. monosodium glutamate)
E622 – Monokaliumglutamat (engl. monopotassium glutamate)
E623 – Calciumglutamat
E624 – Monoammoniumglutamat
E625 – Magnesiumglutamat
Diese Bezeichnungen gelten allerdings nur für Glutamate in “Reinform” (>99 %). Substanzen,
die weniger als 99 % enthalten, werden unter unzähligen anderen Namen verarbeitet.
Zutaten, die IMMER Glutamat enthalten (ca. 30-80 %):
Hefeextrakt
autolysierte Hefe
hydrolysierte (Pflanzen-/Gemüse-) Proteine
hydrolysiertes Hafermehl
Pflanzenproteinextrakt
Natriumkaseinat
Calciumkaseinat
texturierte (Soja-/Gemüse-) Proteine (TVP‘s)
Zutaten, die SEHR OFT Glutamat enthalten (ca. 10-40 %):
Malzextrakt
Maltodextrin/Maltodextrose
fermentierter Weizen
(natürliche) Aromen
(pflanzliche/flüssige/Speise-/Fleisch-/Soja-) Würze/Gewürze
gekörnte Brühe
Brühwürfel
Zutaten, die Glutamat enthalten KÖNNEN (bis zu 12 %):
Carrageenan
Enzyme
(konzentrierte/isolierte) Weizen-/Sojaproteine
Sojamilch
Pektin
Lecithin
www.giftig.me Seite 2

Unternehmen die freies Glutamat MSG im großen Stil einsetzen
KFC – ist einer der gefährlichsten, ist auch in den MSG-Skandal sehr stark verstrickt.
Burger King – sehr viele Produkte
McDonald‘s – viele Produkte
Nestle – einige Produkte
Pizza Hut – viele Produkte
Umami Burger – viele Produkte
EINIGE DER MSG STUDIEN STUDIEN
Latest MSG study in rural China shows that MSG contributes to obesity in
humans, regardless of caloric intake and activity.
Ahmad, K. and K. Jahan. Studies on the Preventative and Curative Action of Ascorbic Acid
on the Neurological Toxicity of Monosodium Glutamate. Institute of Nutritional and Food
Science - University of Dhaka.
Aizenman, E., Frosch, M.P., and Lipton, S.A. 1988. Responses Mediated by Excitatory Amino
Acid Receptors in Solitary Retinal Ganglion Cells from Rat. J. Physiol 395: 75-91.
Arbogast, Lydia A. and James L. Voogt. 1990. Sex-Related Alterations in Hypothalamic
Tyrosine Hydroxylase After Neonatal Monosodium Glutamate
Treatment. Neuroendocrinology 52 (5): 460-7.
Arndt, T. et al. 1993. Reduced, Positive Nitrogen Balance and Elevated Plasma Free Fatty
Acid Concentration in Growing, Glutamate-induced Obese Rats. Journal of Experimental
Animal Science 36(1):12-8.
Aschner, M er al. 1990. Interactions of Methylmercury with Rat Primary Astrocyte
Cultures: Inhibition of Rubidium and Glutamate Uptake and Induction of Swelling. Brain
Research 530 (2): 245-50.
Aust, L. et al. 1993. Postprandial Thermogenesis of Rats With Glutamate Induced Obesity
in Relation to Energy Intake. Zeitschrift fur Ernahrungswissenschaft 32(1):71-3.
Banister, E. W. et al. 1978. Effect of High-Pressure Oxygen on Cellular Fine Structure,
Ammonia and Glutamate Metabolism. Underwater Physiology: 215-232.
Barbour, B. et al. 1991. Electrogenic Uptake in Glutamate and Aspartate into Glial Cells
Isolated from the Salamander (Ambystoma) Retina. J Physiol 436: 169-183.
www.giftig.me Seite 3

Bennett, Gary J. 1998. The Role of Glutamate in Chronic Inflammatory Pain and Painful
Peripheral Neuropathies. Speaker, NIH National Meeting. The Glutamate Cascade: Common
Pathways of Central Nervous System Disease States. May3-5, 1998.
Betraan, M.A. et al. 1992. Nitrogen Metabolism in Obesity Induced by Monosodium-L-
Glutamate in Rats. International Journal of Obesity and Related Metabolic
Disorders 16(8):555-64.
Botey, J. et al. 1988. Monosodium Glutamate and Skin Pathology in Pediatric
Allergology. Allergology and Immunopathology 16 (6) 425-428.
Broadwell, R.D. and Sofroniew. 1993. Serum Proteins Bypass the Blood-Brain Fluid Barriers
For Extracellular Entry to the Central Nervous System. Experimental Neurology 120:245-
263.
Bruno, V. et al. 1994. Protective Action of Idebenone Again Excitotoxic Degeneration in
Cultured Cortical Neurons. Neurosci Lett 178: 193-196.
Cammer, W et al. 1990. Reactive Gliosis in the Brains of Lewis Rats with Experimental
Allergic Encephalomyelitis. Journal of Neuroimmunology 27 (2-3): 111-120.
Canfield, P.R. et al. 1992. Aspartame Exacerbates EEG Spike-wave Discharge in Children
with Generalized Absence Epilepsy: A Double-blind Controlled Study. Neurology 42: 1000-
1003.
Cangro, Charles Benjamin. 1986. Immunocytochemical and Biochemical Investigation into
the Distribution and Metabolism of Glutamate and N-acetylaspartylglutamate Along the
Spinal Sensory Axis. Ph.D. dissertation, Georgetown University. Dissertation Abstracts
Online. 47(2B): 4781.
Chan, P.H. et al. 1990. Attenuation of Glutamate-Induced Neuronal Swelling and Toxicity in
Transgenic Mice Overexpressing Human CuZn-Superoxide Dismutase. Acta Neurochir
Suppl 51: 245-7.
Cheung, W. T. et al. 1988. Neonatal Monosodium -L-Glutamate Treatment Reduced
Lipolytic Response of Rat Epididymal Adipose Tissue. General Pharmacology 19 (4): 507-
512.
Cho, Y. and S. Bannai. 1990. Uptake of Glutamate and Cysteine in C-6 Glioma Cells and in
Cultured Astrocytes. Journal of Neurochemistry 55 (6): 2091-7.
Choi, D.W. 1988. Glutamate Neurotoxicity and Diseases of the Nervous System. Neuron 1:
623-634.
Choi, D.W. 1994. Glutamate Receptors and the Induction of Excitotoxic Neuronal
Death. Prog. Brain. Res. 100: 47-51.
www.giftig.me Seite 4

Choi, D. W. 1990. The Role of Glutamate Neurotoxicity in Hypoxic-Ischemic Neuronal
Death. Annual Review of Neuroscience 13:171-182.
Choi, Dennis W. 1998. Manipulating Glutamatergic Neurotransmission for Therapeutic
Gains: The Example of Brain Ischemia. Speaker, NIH National Meeting. The Glutamate
Cascade: Common Pathways of Central Nervous System Disease States. May3-5, 1998.
Conner-Kerr, Teresa Ann. 1992. A Possible Mechanism of Excitotoxicity: Autoregulation of
Glutamate Release from Hippocampal Mossy Fiber Terminals. Ph.D. dissertation, East
Carolina University. Dissertation Abstracts Online. 53(11B): 5571.
Coyle, J.T. and P. Puttfarcken. 1993. Oxidative Stress, Glutamate, and Neurodegenerative
Disorders. Science 262: 689-695.
Danbolt, N.C. 2001. Glutamate Uptake. Progressive Neurobiology 65(1):1-105.
Dawson, R., Jr. and Z. Annau. 1983. A Behavioral Assessment of Arcuate Nucleus Damage
After a Single Injection of Monosodium Glutamate. Neurobehavioral Toxicology and
Teratology 5 (4): 399-406.
Dawson, R., Jr. et al. 1989. Age and Dose Dependent Effects of Neonatal Monosodium
Glutamate (MSG) Administration To Female Rats. Neurotoxicol. Teratol. 11 (4) 331-337.
Dawson, R., Jr. et al. 1989. A Pharmacological Anaysis of Food Intake Regulation in Rats
Treated Neonatally with Monosodium L-Glutamate (MSG). Pharmacol. Biochem. Behav. 32
(2): 391-398.
Dawson, R., Jr. et al. 1997. Attenuation of Leptin-Mediated Effects by Monosodium
Glutamate (MSG)-Induced Arcuate Nucleus Damage. American Journal of Physiology.
De Erausquin, G. A. et al. 1990. Gangliosides Normalize Distorted Single-Cell Intracellular
Free CA Super (2+) Dynamics After Toxic Doses of Glutamate in Cerebellar Granule
Cells.Proceedings of the National Academy of Sciences, USA 87 (20): 8017-8021.
De Groot, A. P. et al. 1988. Induction of Hyperplasia in the Bladder Epithelium of Rats by a
Dietary Excess of Acid or Base: Implications for Toxicity/Carcinogenicity Testing. Food and
Chemical Toxicology 26 (5): 425-434.
De Schutter, Erik, 1997. A New Functional Role for Cerebellar Long Term
Depression. Progress in Brain Research 114:529-542.
Dolnikoff, M. S. et al. 1988. Neonatal Treatment with Monosodium Glutamate Increases
Plasma Corticosterone in Rat. Neuroendocrinology 48 (6): 645-649.
Dolnikoff, M. S. et al. 2001. Decreased Lipolysis and Enhanced Glycerol and Glucose
Utilization by Adipose Tissue Prior to Development of Obesity in Monosodium Glutamate
(MSG) treated Rats. Int. Journal of Obesity-Related Metabolic Disorders.
www.giftig.me Seite 5

During, M.J. and Spencer, D.D. 1993. Extracellular Hippocampal Glutamate and
Spontaneous Seizure in the Conscious Human Brain. Lancet 341:1607-0610.
Dzogas, Zoran. 1996. In Vivo Activity of Canine Expiratory Bulbospinal Neurons is
Differentially Affected by two Non-N-Methyl-D-Aspartate Receptor Antagonists. Croatian
Medical Journal 37(1).
Eck, H. P. et al. 1990. Partial Recovery of Lymphocyte Activity in Patients with Colorectal
Carcinoma After Curative Surgical Treatment and Return of Plasma Glutamate
Concentrations to Normal Levels. Journal of Cancer Research and Clinical Oncology 116(6):
648-50.
Erdo, S. L. and M. Schaefer. 1991. Memantine is Highly Potent in Protecting Cortical
Cultures Against Excitotoxic Cell Death Evoked by Glutamate and N Methyl-D-
Aspartate. Eur. Journal of Pharmacology 198 (2-3): 215-218.
Favaron, M. et al. 1990. Down-regulation of Protein Kinase C Protects Cerebellar Granule
Neurons in Primary Culture from Glutamate-Induced Neuronal Death. Proceedings of the
National Academy of Sciences of the United States of America 87 (5): 1983-1987.
Fernandez-Aguado, C. et al. 1989. Liver Glutamate and Glutamine Concentration in
Experimental Hepatocarcinogenesis: Effect of Glutathione. Biochem. Chem. Carcinog.,
(Proc. Satell. Symp. 14th Int. Congr. Biochem. ) pp 203-9
Fernstrom, J.D. 2000. Pituitary Hormone Secretion in Normal Male Humans: Acute
Responses to a Large, Oral Dose of Monosodium Glutamate. Journal of Nutrition 130 (Suppl
4s):1053-7.
Fisher, R. S. 1991. Glutamate and Epilepsy. Frontiers of Clinical Neuroscience 11: 131-146.
Frandsen, A. et al. 1990. Novel Glutamate Antagonists Selectively Protect Against Kainic
Acid Neurotoxicity in Cultured Cerebral Cortex Neurons. Journal of Neurochemistry 55 (5):
1821-1823.
Frandsen, A. and Arne Schousboe. 1991. Dantrolene Prevents Glutamate Cytotoxicity and
Calcium Release From Intracellular Stores in Cultured Cerebral Corical Neurons. Journal of
Neurochemistry 56 (3): 1075-8.
Frankel, Arthur et al. 1990. Role of Arginine 180 and Glutamic Acid 177 of Ricin Toxin A
Chain in Enzymic Inactivation of Ribosomes. Molecular Cell Biology 10 (12) 6257-63.
Freese, A. et al. 1990. Characterization and Mechanism of Glutamate Neurotoxicity in
Primary Striatal Cultures. Brain Research 521 (1-2): 254-264.
Fundytus, M.E., 2001. Glutamate Receptors and Nociception: Implications for the Drug
Treatment of Pain. CNS Drugs 2001 Jan: 15(1): 29-58.
www.giftig.me Seite 6

Furkawa, K. et al. 1997. The Actin-severing Protein Gelsolin Modulates Calcium Channel
and NMDA Receptor Activities and Vulnerability to Excitotoxicity in Hippocampal
Neurons. J. Neurosci17: 8178-8186.
Gao, J. et al. 1994. Transplacental Neurotoxic Effects of Monosodium Glutamate on
Structures and Functions of Specific Brain Areas of Filial Mice. Sheng Li Hsueh Pao Acta
Physiologica Sinica46(1):44-51.
Gray, A.M., Rawls, S.M. Shippenberg, T.S., and McGinty, J.F. 1999. Kappa Opioid Agonist, U-
69593, Decreases Acute Amphetamine-evoked Bahaviors andCalcium-dependent Dialysate
Levels of Dopamine and Glutamate in the Ventral Striatum. J Neurochem 73: 1066-1074.
Greene, James G. 1998. Bioenergeetics and Excitotoxicity: An Examination of Neurotoxicity
Secondary to Succinate Dehydrogenase Inhibition. Ph.D. dissertation. The University of
Rochester. Dissertation Abstracts Online. 59(03B): 0933.
Greenmayre, J. and Porter, R. 1994. Anatomy and Physiology of glutamate in the
CNS. Neurol 44: s7-sl3.
Greenmayre, J. Timothy. 1998. Glutamatergic Mechanisms in the Cause and Treatment of
Parkinson’s Disease. Speaker, NIH National Meeting. The Glutamate Cascade: Common
Pathways of Central Nervous System Disease States. May3-5, 1998.
Hahn, J. S. et al. 1988. Central Mammalian Neurons Normally Resistant to Glutamate
Toxicity Are Made Sensitive by Extracellular Ca Super (2+): Toxicity is blocked by the N-
Methyl-D-Aspartate Antagonist. Proceedings of the National Academy of Sciences USA 85
(17) 6556-6560.
Halpain, S., Hipolito, A. and Saffer, L. 1998. Regulation of F-actin Stability in Dendritic Spines
by Glutamate Receptors and Calcineurin. J Neurosci 18: 9835-9844.
Helton, D.R. et al. 1998. Anxiolytic and Side-Effect Profile of LY354740: A Potent, Highly
Selective, Orally Active Agonist for Group II Metabotropic Glutamate Receptors. Journal of
Pharmacology and Experimental Therapeutics 284(2):651-60.
Himi, T. et al. 1990. Spider Toxin (JSTX-3) Inhibits the Convulsions Induced by Glutamate
Agonists. J. Neural Transm. 80 (2): 95-104.
Hussain, M.M. et al. 1989. Characterization of Glutamate Dehydrogenase Isoproteins
Purified From the Cerebellum of Normal Subjects and Patients with Degenerative
Neurological Disorders, and From Human Neoplastic Cell Lines. Journal of Biol.
Chemistry 264 (34): 20730-735.
Ishikawa, K et al. 1997. Hippocampal Degeneration Inducing Impairment of Learning in
Rats: Model of Dementia? Behavioural Brain Research 83(1-2):39-44.
Janssen, Raelyn et al. 1991. Glutamate Neurotoxicity in the Developing Rat Cochlea:
Physiological and Morphological Approaches. Brain Research 552 (2): 255-64.
www.giftig.me Seite 7

Jensen, Frances E. 1998. Role of Glutamate Receptor Maturation in Perinatal Brain
Injury. Speaker, NIH National Meeting. The Glutamate Cascade: Common Pathways of
Central Nervous System Disease States. May3-5, 1998.
Kato, S. et al. 1990. Gliotoxic Effects of Alpha- Aminodipic Acid Isomers on the Carp Retina:
A Long Term Observation. Neuroscience 36 (1): 145-153.
Kayastha, Arvind M. et al. 1991. Site-Directed Mutagenesis of the Beta Subunit of
Tryptophan Synthase From Salmonella Typhimurium. Role of Active Site Glutamic Acid. J.
Biol. Chem. 266 (12): 7618-25.
Kirchgessner, A. L. et al. 1997. Excitotoxicity in the enteric nervous system. Journal of
Neuroscience 17:8807-8816.
Kiskin, N. I. et al. 1989. Blocking Action of Nephalia Clavata Spider Toxin on Ionic Currents
Activated by Glutamate and its Agonists in Isolated Hippocampal
Neurons. Neurophysiology 21 (2): 110-116.
Klunk, W. E. et al. 1991. L Phosphoserine A Metabolite Elevated in Alzheimer's Disease
Interacts with Specific L Glutamate Receptor Subtypes. Journal of Neurochem 56 (6): 1997-
2003.
Koh, B.K., et al. 1996. Effects of Cysteine on Free Radical Production and Protein
Modification in Extruded Wheat Flour. Cereal Chem 73(1): 115-122.
Koh, Jaeyoung. 1989. Glutamate Receptor-Mediated Neurotoxicity in Murine Neuronal
Cultures. Ph.D. dissertation, Stanford University. Dissertation Abstracts Online 50(12B):
5486.
Kristova, V. et al. 1998. Early Postnatal Glutamate treatment Results in Altered Vascular
Responsiveness to Seratonin and Noradrenaline in Adult Rats. Endocrine
Regulations 32:133-139.
Kubo, T. et al. 1993. Neonatal Glutamate Can Destroy the Hippocampal CA1 Structure and
Impair Discrimination Learning in Rats. Brain Research 616:311-314.
Kurozumi, K. et al. 1990. Generation of Inositol Phosphates, Cytosolic Ca2+, and Secretion
of Noradrenaline in PC12 Cells Treated with Glutamate. FEBS Lett. 270 (1-2): 225-8.
Lipton, S. and Rosenberg, P. 1994. Excitatory Amino Acids as a Final Common Pathway for
Neurologic Disorders. New England Journal of Medicine. 330: 613-622.
Lipton, Stuart A. 1998. Excitotoxic Apoptosis and Necrosis in AIDS Dementia and Stroke:
Potential Treatment with NMDA Open-channel Blockers and Nitric Oxide Related
Species. Speaker, NIDA meeting, The Glutamate Cascade. Brigham and Women’s Hospital
and Harvard Medical School.
www.giftig.me Seite 8

Liu, W. K. et al. 1989. Effects of Neonatal Monosodium-L-Glutamate Treatment on Rat
Alveolar Macrophages. Chemical Biological Interactions 69 (2-3): 193-201.
Liu, M. T. et al. 1999. Identification and characterization of Glucoresponsive Neurons in the
Enteric Nervous System. Journal of Neuroscience 19:10305-10317.
Lovinger, David M. et al. 1990. Ethanol Inhibition of Neuronal Glutamate Receptor
Function. Ann. Med. 22 (4): 247-52.
Lundberg A/S, H. 2002. Data on Ebixa for Treatment of Alzheimer's Disease. H.Lundberg
A/S Press Release #73 Date 22-07-2002
Machado, U. F. et al. 1993. Decreaeed Glucose Transporter GLUT 4 Content in Insulin-
Sensitive Tissues of Obese Aurothioglucose- and Monosodium Glutamate-Treated
Mice. Hormone and Metabolic Research 25(9):462-5.
Magalhaes, J. R. 1989. Ammonium Assimilation in Different Plant Species as Affected by
Nitrogen Form and pH Control in Solution Culture. Fertilizer Research 21 (1): 1-6.
Margarinos, A. M. et al. 1988. Regulation of the Central Nervous System-Pituitary-Adrenal
Axis in Rats After Neonatal Treatment With Monosodium
Glutamate. Neuroendocrinology 48 (2): 105-111.
Marc, R. E. and Lam, D.M.K. 1981. Uptake of Aspartic and Glutamic Acid by Photoreceptors
in Goldrish Retina. Proc. Natl. Acad. Sci. 78: 7185-7189.
Marinez, F. et al. 1993. Neuroexcitatory Amino Acid Levels in Plasma and Cerebrospinal
Fluid During Migraine Attacks. Cephalagia 13(2):89-93.
Maulucci-Gedde, M and D. W. Choi. May 1987. Coritical Neurons Exposed to Glutamate
Rapidly Leak Preloaded Chromium. Experimental Neurology 2: 420-429.
Max, Mitchell B. 1998. Effect of Glutamate Blockers on Human Pain. Speaker, NIDA
meeting, The Glutamate Cascade. Institute of Dental Research, National Institutes of Health.
McDonald, J. W. and M.V Johnston. 1993. Excitatory Amino Acid Neurotoxicity in the
Developing Brain. NIDA Research Monograph 133:185-205.
McMahon, Harvey T. et al. 1990. Alpha-Latrotoxin Releases Both Vesicular and Cytoplasmic
Glutamate From Isolated Nerve Terminals. Journal of Neurochemistry 55 (6) 2039-47.
Miaskowiak, B. and M. Partyka. 1993. Effects of Neonatal Treatment with MSG
Monosodium Glutamate on Hypothalamo-Pituitary-Thyroid Axis in Adult Male
Rats. Histology and Histopathology8(4):731-4.
Miaskowiak, B. and M. Partyka. 1993. Effect of Perinatal Administration of Monosodium
Glutamate MSG on the Reproductive System of the Male Rat. Endokrynologia Polska 44
(4):497-505.
www.giftig.me Seite 9

Michaels, R. L. and S. M. Rothman. 1990. Glutamate Neurotoxicity in Vitro: Antagonist
Pharmacology and Intracellular Calcium Concentrations. Journal of Neuroscience 10 (1):
283-292.
Michaelis, E. K. 1990. Glutamate Receptor Changes in Brain Synaptic Membranes From
Human Alcoholics. Neurochem. Research 15 (11): 1055-63.
Milani, D. et al. 1991. Excitatory Amino-Acid Induced Alterations of Cytoplasmic Free
Calcium in Individual Cerebellar Granule Neurons: Role in Neurotoxicity. J. Neurosci. Res.
28 (3): 434-41.
Miller, S. M. and B. Magasanik. 1990. Role of NAD-Linked Glutamate Dehydrogenase in
Nitrogen Metabolism in Saccharomyces Cerevisiae. Journal of Bacteriology 172(9): 4927-35.
Miyamoto, M et al. 1989. Antioxidants Protect Against Glutamate-Induced Cytotoxicity in a
Neuronal Cell Line. Journal of Pharmacology and Experimental Therapy 250 (3) 1132-1140.
Mohammed, A. K. et al. 1990. Behavioural Deficits and Seratonin Depletion in Adult Rats
After Transient Infant Nasal Viral Infection. Neuroscience 35 (2): 355-63.
Morrison, John H. 1998. Glutamate Receptor Plasticity in the Hippocampus: Implications
for Aging. Speaker, NIDA meeting, The Glutamate Cascade Fishberg Research Center for
Neurobiology and Mount Sinai School of Medicine.
Mural, R. J. et al. 1990. Examination of the Intersubunit Interaction Between Glutamate-48
and Lysine-168 of Ribulose-Bisphosphate Carboxylase/Oxygenase by Site-Directed
Mutagenisis. J. Biol. Chemistry 265(11): 6501-6505.
Murphy, T. H. et al. 1990. Immature Cortical Neurons are Uniquely Sensitive To Glutamate
Toxicity by Inhibition of Cystine Uptake. FASEB Journal 4 (6): 1624-1633.
Murphy, T. H. et al. 1991. Enhanced NAD (P) H:Quinone Reductase Activity Prevents
Glutamate Toxicity Produced by Oxidative Stress. Journal of Neurochemistry 56 (3): 990-
995.
Murphy, T. H et al. 1989. Glutamate Toxicity in a Neuronal Cell Line Involves Inhibition of
Cystine Transport Leading to Oxidative Stress. Neuron 2 (6): 1547-58.
Murphy, T.H. and J. M. Baraban. 1990. Glutamate Toxicity In Immature Cortical Neurons
Precedes Development of Glutamate Receptor Currents. Dev. Brain Research 57 (1): 146-
150.
Mytilineou, C et al. 1997. L-(-)Desmethyiselegeline, a Metabolite of Selegeline (L-(-)-
deprenyl, Protects Mesencephalic Dopamine Neurons From Excitotoxicity in Vitro. J
Neurochem 68: 434-436.
Miyamoto, M. and Coyle J. 1990. Idebenone Attenuates Neuronal Degeneration Induced by
Intrastriatal Injection of Excitotoxins. Exp Neurol 108: 38-45.
www.giftig.me Seite 10

Miyamoto, M. et al. 1989. Antioxidants Protect Against Glutamate-induced Cytotoxicity in
a Neuronal Cell Line. J Pharmacol Exp Ther 250: 1132-1140.
Murphy, Timothy H. 1989. Glutamate Toxicity in a Neuronal Cell Line Involves Inhibition of
Cystine Uptake Leading to Oxidative Stress. Ph.D. dissertation. The Johns Hopkins
University. Dissertation Abstracts Online. 50(07B): 2863.
Nakanishi, Koji, et al. 1990. Philanthotoxin-433 (PHTX-433), A Non-competitive Glutamate
Receptor Inhibitor. Pure Applied Chemistry 62 (7): 1223-30.
Nenoff, P. et al. 1993. In Vivo Assessment of Insulin Binding in Different Organs of Growing
and Adult Glutamate-Induced Obese Rats. Experimental and Clinical
Endocrinology 101(4):215-21.
Nishimura, Atsushi. 1990. Neonatal Glutamate-Induced Cerebral Cortical Degeneration in
Rats. Nichidai Igaku Zasshi 49 (12): 1131-9.
Nowak, L., Bregestovski, P. et al. 1984. Magnesium Gates Glutamate-activated Channels in
Mouse Central Neurones. Nature 307: 462-465.
O' Brien, J. et al. 1984. Toxicity of Maillard Reaction Products of Monosodium Glutamate
and Glucose in Rats. Irish Journal of Food Science and Technology 8 (1): 77.
O' Brien, J. and R. Walker. 1988. Toxicological Effects of Dietary Maillard Reaction Products
in the Rat. Food and Chemical Toxicology 26 (9): 775-784.
O’Hearn, E. and Molliver, M.E. 1999. Neurotoxins and Neuronal Death: An Animal Model of
Excitotoxicity. In V.E. Koliatsos (ed): Cell Death and Diseases of the Nervous System. Totowa,
Humana Press. pp 221-245.
Olney, J. W. and M. T. Price. 1986. Cholinergic Neurotoxicity: Mechanisms and
Prevention. Washington University, St. Louis MO Dept of Psychiatry Annual Report.
Olney, J. et al. 1998. Excitotoxic Neurodegeneration in Alzheimers Disease. Arch Neurol 54:
1234-1240.
Olney, J.W., Wozniak, D.F., Farber, N.B. 1997. Excitotoxic Neurodegeneration in Alzheimer
Disease, New Hypothesis and New Therapeutic Strategies. Arch Neurol Oct: 54(10): 1234-
1240.
Olney, J.W. et al. 1996. Increasing Brain Tumor Rates: Is there a Link to Aspartame? Journal
of Neuropathology and Experimental Neurology 55:1115-23.
Olney, J. W.1994. Excitotoxins in Foods. Neurotoxicology 15:535-44.
Olney, J. W. 1990. Excitotoxin Mediated Neuron Death in Youth and Old Age. Progress in
Brain Research 86:37-51.
www.giftig.me Seite 11

Olney, J. W. 1990. Excitotoxin Amino Acids and Neuropsychiatric Disorders. Annual Review
of Pharmacology and Toxicology 30:47-71.
lney, J. 1989. Glutamate, a Neurotoxic Transmitter. J Child Neurol 4: 218-226.
Olney, J.W. and M.T. Price. 1980. Neuroendocrine Interactions of Excitatory and Inhibitory
Amino Acids. Brain Research Bulletin 5 (Suppl 2): 361-368.
Olney, J. W. et al. 1977. Neurotoxic Effects of Glutamate on Mouse Area Postrema. Brain
Research 120: 151-157.
Olney, J.W. 1974. Toxic Effects of Glutamate and Related Amino Acids on the Developing
Central Nervous System. Inherited Disorders of Amino Acid Metabolism, W. N. Nylan, New
York, Wiley.
Olney, J. W. et al. 1973. Brain-Damaging Potential of Protein Hydrolysates. New England
Journal of Medicine 289: 391-393.
Olney, J. W. et al. 1971. Cytotoxic Effects of Acidic and Sulphur Containing Amino Acids on
the Infant Mouse Central Nervous System. Experimental Brain Research 14:61-76.
Olney, J.W. and O.L. Ho. 1970. Brain Damage in Infant Mice Following Oral Intake of
Glutamate, Aspartate or Cysteine. Nature 227:609-610.
Olney, J.W. 1969. Glutamate-induced retinal degeneration in neonatal mice. Journal of
Neuropathology and Experimental Neurology 28:455-474.
Olney, J.W. 1969. Brain Lesions, Obesity, and Other Disturbances in Mice Treated with
Monosodium Glutamate. Science 164:719-721.
Olney, J. W. and L.G. Sharpe. 1969. Brain Lesions in an Infant Rhesus Monkey Treated With
Monosodium Glutamate. Science 166:386-388.
Orpana, Arto K. 1990. Ethanol-Induced Inhibition of Testosterone Biosynthesis in Rat Leydig
Cells: Role of L-Glutamate and Pyruvate. Journal of Steroid Biochem. 36 (5): 473-8.
Pike, R.N., D. Bagarozzi Jr and J. Travis. 1997. Immunological cross-reactivity of the Major
Allergen from Perennial Ryegrass (Lolium Perenne), L01 pI, and the Cysteine Proteinase,
Bromelain. Int. Arch. Allergy Immunol. 1123: 412-414.
Pol, A. et al (1990). Glutamate, the Dominant Excitatory Transmitter in Neuroendocrine
Regulation. Sci 250: 1276-1278
Portais, J. C. et al. 1991. Magnetic Resonance Spectroscopy and Metabolism. Applications
of Proton and 13C NMR to the Study of Glutamate Metabolism in Cultured Glial Cells and
Human Brain In Vivo. Biochimie 73 (1): 93-7.
www.giftig.me Seite 12

Privat, Alain et al. 1990. Neuronal Protection by Phenycyclidines: In Vitro
Studies. Actual. Chim. Ther. 17: 187-200.
Pulvirenti, Luigi. 1998. Glutamate During the Natural History of Psychostimulant
Dependence: Synaptic Plasticity and Medications Development. Speaker, NIDA meeting,
The Glutamate Cascade. University of Rome – Tor Vergata, Italy.
Rao, G. S. and K. P. Pandya. 1989. Release of 2-Thiobarbituric Acid Reactive Products From
Glutamate or Deoxyribonucleic Acid by 1, 2, 4-Benzenetriol or Hrdroquinone in the
Presence of Copper Ions. Toxicology 59 (1): 59-65.
Rawls, S.M., McGinty, J.F., 1998. Presynaptic Kappa Opioid and Muscarinic Receptors
Inhibit the Calcium-dependent Component of Evoked Glutamate Release from Striatal
Synaptosomes. J Neurochem. 73: 1058-1065.
Rawls, S.M., McGinty, J.F. 1998. Kappa Receptor Activation Attenuates L-trans-PDC-evoked
Glutamate Levels in the Striatum. J Neurochem 70: 626-634.
Rigdon, G. C. et al. 1989. Effect of Perinatal Monosodium Glutamate Administration on
Visual Evoked Potentials of Juvenile and Adult Rats. Neuro-Toxicology and Teratology 11
(2): 121-128.
Roberts, H.J. 1988. Reactions Attributed to Aspartame-containing Products: 551 Cases. J
App Nutr 40: 85-94.
Roberts, H.J. 1995. Aspartame and Headache. Neurology 45: 1631-1633.
Roberts, H.J. 1988. Aspartame (NutraSweet®)-associated Epilepsy. Clin Res 36: 349A.
Roberts, H.J. 1988 Complications Associated with Aspartame (NutraSweet®) in
Diabetes. Clin Res 3: 489A.
Roberts, H.J. 1991. Joint Pain Associated with Aspartame Use. Townsend letter for
Doctors. May: 375-376.
Roberts, H.J., 1993 Aspartame-associated Dry Mouth (Xerostomia). Townsend letter for
Doctors. February: 201-202.
Rochelle, Lori G. et al. 1990. Chlordecone Impairs Sodium-Stimulated l-(3h) Glutamate
Transport and Mobility of 16-Doxyl Stearate in Rat Liver Plasma Vesicles. Toxicol. Appl.
Pharacol. 105 (2): 234-42.
Rogawski, Michael E. 1998. Glutamate Neurotransmission in Epilepsy: New Treatment
Strategies. Speaker, NIDA meeting, The Glutamate Cascade. National Institute of
Neurological Disorders and stroke, National Institutes of Health.
www.giftig.me Seite 13

Rosenberg, P.A., and E. Aizenman. 1989. Hundred-fold Increase in Neuronal Vulnerability to
Glutamate Toxicity in Astrocyte-Poor Cultures of Rat Cerebral Cortex. Neuroscience
Letters 103 (2): 162-168. 116 (3) 399.
Rothstein, J.D. et al. 1992. Decreased Glutamate Transport by the Brain and Spinal Cord in
Amyotropic Lateral Sclerosis. New England Journal of Medicine 326:1464-1468.
Ruijter, J. M. and R. E. Baker. 1990. The Effects of Potassium-Induced Depolarization,
Glutamate Receptor Antagonists and N-Methyl-D-Aspartate on Neuronal Survival in
Cultured Neocortex Explants. Int. J. Dev. Neurosci. 8 (4): 361-70.
Sanico, Alvin, et al. 2000. Researchers Present New Theory for Allergic Diseases. American
Journal of Respiratory and Critical Care Medicine.
Schweitzer, L. et al. 1991. Glutamate Neurotoxicity in Rat Auditory System Cochlear
Nuclear Complex. Neurotoxicology Teratol 13 (2): 189-194.
Shapiro, B. H. et al. 1993. Irreversible Suppression of Growth Hormone-Dependent
Cytochrome P450 2C11 in Adult Rats Neonatally Treated with Monosodium
Glutamate. Journal of Pharmacology and Experimental Therapeutics 265(2):979-84.
Shinora, S. et al. 1991. Inhibitory Effect of CCK-8 and Ceruletide on Neuronal Cell Death
Induced by Glutamate and its Possible Mechanism. 64th Annual Meeting of the Japanese
Pharmacological Society 55 (Suppl. 1): 303.
Siegal, T. et al. 1990. Experimental Neoplastic Spinal Cord Compression: Effect of Anti-
Inflammatory Agents and Glutamate Receptor Antagonists on Vascular
Permeability. Neurosurgery 26 (6): 967-70.
Simantov, R. 1989. Glutamate Neurotoxicity in Culture Depends on the Presence of
Glutamine: Implications for the Role of Glial Cells in Normal and Pathological Brain
Development. Journal of Neurochemistry 52 (6): 1694-9.
Singh, J. et al. 1990. Effect of Aspartate and Glutamate on Carbon Tetrachloride Induced
Liver Damage in Rats. Indian Journal of Experimental Biology 28 (12): 1180-3.
Smith, J.D. et al. 2001. Relief of Fibromyalgia Symptoms Following Discontinuation of
Dietary Excitotoxins. Annals of Pharmacotherapy 35(6):702-6.
Solimena, M et al. 1990. Auto-antibodies to GABA-ergic Neurons and Pancreatic Cells in
Stiff-man Syndrome. New England Journal of Medicine 322:1555-1560.
Sorg, O. et al. 1997. Inhibition of Astrocyte Glutamate Uptake by Reactive Oxygen Species:
Role of Antioxidant Enzymes. Mol. Med 7: 431-440.
Sucher, N.J. et al. 1991. Calcium Channel Antagonists Attenuate NMDA Receptor-Mediated
Neurotoxicity of Retinal Ganglion Cells in Culture. Brain Research 551 (1-2): 297-302.
www.giftig.me Seite 14

Summers, M.J. 1995. Administration of Glutamate Following a Reminder Induces Transient
Memory Loss in Day-old Chicks. Brain Research 3(1):1-8.
Tamura, Y. et al. 1991. Ifenprodil-Induced Protection Against Glutamate Cytotoxicity in
Primary Culture of Cortical Neurons. 64th Annual Meeting of the Japanese Pharmacological
Society 55 (Suppl. 1): 297.
Tang-Christensen, M. et al. 1998. Glucagon-like Peptide 1 7-36 amide's Central Inhibition of
Feeding and Peripheral Inhibition of Drinking Are Abolished by Neonatal Monosodium
Glutamate Treatment. Diabetes 47(4):530-7
Tarkowski, S. 1974. Activity of Glutamate Decarboxylase in the Brain of Rats Exposed to
Carbon Disulfide. International Archiv Fuer Arbeitsmedizin 33 (1) 79-82.
Teal, G.E. et al. 1998. Increased Glutamatergic Neurotransmission and Oxidative Stress
After Alcohol Withdrawal. Am J Psychiat 155: 726-732.
Terrian, David, M. et al. 1991. Domoic Acid Enhances the Potassium-Evoked Release of
Endogenous Glutamate From Guinea Pig Hippocampal Mossy Fiber Synaptosomes. Brain
Research 551 (1-2): 303-7.
Tomita, M et al. 1990. Ionic Concentration of Shifting Fluid During Glutamate-Induced
Swelling of Cultured Glioma Cells Estimated by the Cytocrit Technique. Adv. Neurology 52:
558.
Tzimagiorgis, G. et al. 1991. Chromosomal Mapping of Glutamate Dehydrogenase Gene
Sequences to Mouse Chromosomes 7 and 14. Genomics 10 (1) 83-8.
Villalobos, Carlos et al. 1996. Functional Glutamate Receptors in a Subpopulation of
Anterior Pituitary Cells. FASEB J. 10: 654-660.
Vornov, J. J. and J. T. Coyle. 1991. Glutamate Neurotoxicity and the Inhibition of Protein
Synthesis in the Hippocampal Slice. Journal of Neurochemistry 56 (3): 996-1006.
Walling, Anne D. Predicting Which Strokes Will Progress: Glutamate Levels. 1997. American
Family Physician: 55(7): 2532(1).
Wang, J.Q., McGinty, J.F. 1999. Glutamate-dopamine Interactions Mediate the Effects of
Psychostimulant Drugs. Addiction Biology. 4: 143-152.
Weeing-Verhoeff, E. J. D. et al. 1990. Involvement of Aspartic and Glutamic Residues in
Kringle-2 of Tissue-Type Plasminogen activator in Lysine Binding, Fibrin Binding and
Stimulation of Activity as Revealed by Chemical Modification and Oligonucleotide-Directed
Mutagenesis. Protein Engineering 4 (2) 191-8.
Whetsell, W. and Shapira, N. 1993. Biology of Disease. Neuroexcitation, Excitotoxicity and
Human Neurological Disease. Lab Invest 68: 372-387.
www.giftig.me Seite 15

Wolf, Marina E. 1998. Glutamate-Mediated Neuroplasticity: Role in Amphetamine
Addiction. Speaker, NIDA meeting, The Glutamate Cascade. The Chicago Medical School.
Wong, C. C. et al. 1988. Effect of Neonatal Monosodium-L-Glutamate Treatment on the
Response of Isolated Uterine Preparation To Various Uterine Contraction Stimulators. Gen.
Pharmacol.19 (5): 673-677.
Wong, P.T. et al. 1997. Deficits in Water Escape Performance and Alterations in
Hippocampal Cholinergic Mechanisms Associated with Neonatal Monosodium Glutamate
Treatment in Mice.Pharmacology, Biochemistry and Behaviour 57(1-2):383-8.
Xu, C. J. et al. 1997. Effect of Phosphomonoesters, Phosphodiesters, and PhosphoCreatine
on Glutamate Uptake by Synaptic Vesicles. Molecular and Chemical Neuropathology 32(1-
3):89-99.
Yamamoto, T, et al. 1993. Plasma Levels of Insulin-like Growth Factor-I are Reduced at one
Week of Age in Monosodium L-Glutamate-Treated Mice. Endocrine Journal 40(4):461-5.
Yanai, A. et al. 1991. 4-0 Methylpyridoxine-Induced Convulsion Accompanied by a
Decreased Cerebral GABA Level in Guinea Pigs. 64th Annual Meeting of the Japanese
Pharmacological Society55 (Suppl. 1): 303.
Yokota, I. et al. 1990. Molecular Basis of Medium Chain Acyl-Coenzyme A Dehydrogenase
Deficiency. An A to G Transition at Position 985 That Causes a Lysine-304 to Glutamate
Substitution in the Mature Protein is the Single Prevalent Mutation. J. Clinical Invest. 86 (3):
1000-1003.
Yu, T. et al. 1997. Effects of Maternal Oral Administration of Monosodium Glutamate at a
Late Stage of Pregnancy on Developing Mouse Fetal Brain. Brain Research 747(2):195-206.
Zeevalk, G. D. and W. J. Nicklas. 1990. Chemically Induced Hypoglycemia and Anoxia:
Relationship To Glutamate Receptor-Mediated Toxicity in Retina. J. Pharmacology and
Experimental Therapy 253 (3): 1285-1292.
Zharikov, S. I. et al. 1990. Effect of Alpha-Latrotoxin on the Processes of Glutamate Uptake
and Release in Rat Brain Synaptosomes. Biol. Membr. 7(10): 101321
Zhao, X. N. et al. 1990. Morphine Enhancement of Glutamate and Kainic Acid
Neurotoxicity. Met. Ions Biol. Med. Proc. Int. Symp. pp 156-8.
Zieglgansberger, Walter and Planck, M. 1998. Acamprosate, a Novel Anti-craving
Compound Acts Via Glutamatergic Pathways. Speaker, NIDA meeting, The Glutamate
Cascade. Institute of Psychiatry, Munich, Germany.
Zukin, Stephen R. 1998. Schizophrenia: A Glutamatergic Perspective. Speaker, NIDA
meeting, The Glutamate Cascade. National Institute on Drug Abuse, National Institutes of
Health.
www.giftig.me Seite 16

www.giftig.me Seite 17